Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
by Matthew Lewis, MD
Virtual (Zoom)
Learn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations and a treatment option for appropriate BP patients
Clinical Case Discussion: An Adult Patient with Prurigo Nodularis and a Treatment Option for Appropriate Patients 18+ Years of Age
by Michael Payette, MD
Virtual (Zoom)
Join us for a program discussing a real-world case of an adult patient with prurigo nodularis (PN) and a treatment option that may help appropriate patients.
Clinical Case Discussion: A Pediatric Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
by Dareen Siri, MD
Virtual (Zoom)
Join us for a program discussing a real-world case of a pediatric patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation.
DUPIXENT® (dupilumab) Pediatric Caregiver Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Dareen Siri, MD
Virtual (Zoom)
Join us for a virtual discussion with an expert speaker and a caregiver of a pediatric patient with atopic dermatitis (AD) to learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
The Shades of Atopic Dermatitis in Skin of Color and a Treatment Option for Appropriate Patients with Type 2 Inflammation
by Fred Ghali, MD
Virtual (Zoom)
Learn more about the distinctive ways that atopic dermatitis (AD) may present in patients with skin of color and a treatment option that may help appropriate patients with Type 2 inflammation.
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients.
by Linda Stein Gold, MD
Virtual (Zoom)
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Eileen Cheever, PA-C
Virtual (Zoom)
This program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. Register
DUPIXENT@ (dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Zakiya Rice, MD
Virtual (Zoom)
Join us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
Clinical Case Discussion: An Adult Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
by Marshall Shuler, MD
Virtual (Zoom)
Join us for a program discussing a real-world case of an adult patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation
Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
by Timothy Patton, DO
Virtual (Zoom)
Learn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations and a treatment option for appropriate BP patients